Q2 FY2026 EarningsQ2 FY26 results beat consensus on revenue ($34.5M vs. $34.0M expected) but missed significantly on EBIT and EPS due to heavy interest expenses and non-cash items. Pre-commercial product revenue for BOT/BAL contributed $6.4M, indicating early traction in access programs. While a $40.4M gain from the Zydus asset sale bolstered H1 results, the company continues to face a liquidity-driven 'going concern' warning, partially mitigated by a $85M post-quarter private placement.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Agenus(AGEN) the Revenue is 34.5 M (+34.24%), Beat estimate;the EBIT is 11.3 M (+167.6%), Miss estimate;the EPS is -0.01 (+99%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B34.24%
0.03B32.30%
+0.00B1.94%
EBITMiss expectations
0.01B167.62%
0.02B199.63%
-0.01B32.01%
EPSMiss expectations
-0.0199.00%
0.045104.50%
-0.05505.50%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf